Earnings Release • May 10, 2018
Earnings Release
Open in ViewerOpens in native device viewer

Asher Grinbaum | Acting CEO May 10th , 2018
The information contained herein in this presentation or delivered or to be delivered to you during our presentation does not constitute an offer, expressed or implied, or a recommendation to do any transaction in Israel Chemicals Ltd. ("ICL" or "Company") securities or in any securities of its affiliates or subsidiaries.
This presentation and/or other oral or written statements made by ICL during its presentation or from time to time, may contain forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 and other applicable securities laws. Whenever words such as "believe," "expect," "anticipate," "intend," "plan," "estimate", "predict" or similar expressions are used, the Company is making forward-looking statements. Such forward-looking statements may include, but are not limited to, those that discuss strategies, goals, financial outlooks, corporate initiatives, existing or new products, existing or new markets, operating efficiencies, or other non-historical matters.
Because such statements deal with future events and are based on ICL's current expectations, they could be impacted or be subject to various risks and uncertainties, including those discussed in the "Risk Factors" section and elsewhere in our Annual Report on Form 20-F for the year ended December 31, 2017, and in subsequent filings with the Tel Aviv Securities Exchange (TASE) and/or the U.S. Securities and Exchange Commission (SEC). Therefore actual results, performance or achievements of the Company could differ materially from those described in or implied by such forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can provide no assurance that expectations will be achieved. Except as otherwise required by law, ICL disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date hereof, whether as a result of new information, future events or circumstances or otherwise. Readers, listeners and viewers are cautioned to consider these risks and uncertainties and to not place undue reliance on such information.
Certain market and/or industry data used in this presentation were obtained from internal estimates and studies, where appropriate, as well as from market research and publicly available information. Such information may include data obtained from sources believed to be reliable, however ICL disclaims the accuracy and completeness of such information which is not guaranteed. Internal estimates and studies, which we believe to be reliable, have not been independently verified. We cannot assure that such data is accurate or complete.
Included in this presentation are certain non-GAAP financial measures, such as Adjusted Operating income and Adjusted Net income, designed to complement the financial information presented in accordance with IFRS because management believes such measures are useful to investors. These non-GAAP financial measures should be considered only as supplemental to, and not superior to, financial measures provided in accordance with IFRS. Please refer to our Q1 2018 press release for the quarter ended March 31, 2018 for a reconciliation of the non-GAAP financial measures included in this presentation to the most directly comparable financial measures prepared in accordance with IFRS.

| \$ millions | Q1 18 | Q1 17 | % change | Q4 17 | % change |
|---|---|---|---|---|---|
| Sales | 1,404 | 1,295 | 8.4% | 1,361 | 3.2% |
| Adjusted operating income | 151 | 116 | 30.2% | 168 | (10.1)% |
| Adjusted net income | 106 | 68 | 55.9% | 142 | (25.4) % |
| Operating income | 985 | 116 | 749.1% | 189 | 421.2% |
| Net income |
928 | 68 | 1,264.7% | 155 | 498.7% |
| Net Debt | 2,269 | 3,262 | (30.4)% | 3,037 | (25.3)% |
| Average potash selling price - FOB |
244 | 216 | 13.0% | 222 | 9.9% |
See Q1 2018 press release for a reconciliation of Adjusted operating income to operating income, adjusted net income to net income
| Specialty Solutions | Essential Minerals | ||||
|---|---|---|---|---|---|
| \$ million | Q1 2018 | Q1 2017 | % change | ||
| 659 | 613 | 7.5% | |||
| 131 | 115 | 13.9% |
| \$ million | Q1 2018 | Q1 2017 | % change | |||
|---|---|---|---|---|---|---|
| Sales* | 814 | 734 | 10.9% | |||
| Segment O/I** | 90 | 66 | 36.4% |
Reduce debt ratios while still investing in growth
Continuous improvement in the competitiveness of our mineral assets in Europe, China and Israel
Focus on specialty agriculture growth
Continue both organic and inorganic growth of Specialty businesses
Grow post-divestment Advanced Additives
Return to growth trajectory in Food Specialties
Maintain high profit margins at Industrial Products
Complete transition to Polysulphate at ICL UK.
Executing long-term infrastructure CapEx projects
Net Debt/EBITDA = 2.3 (2.9 in Dec. 2017)*
Positive operating margins at ICL Iberia and YPH JV, significant reduction in operating loss at ICL-UK




Growth in Semi-Specialty
Growth through leadership in Advanced Crop Nutrition

Kobi Altman CFO
| \$ millions | Q1 18 | Q1 17 | % change | Q4 17 | % change |
|---|---|---|---|---|---|
| Sales | 1,404 | 1,295 | 8.4% | 1,361 | 3.2% |
| Adjusted operating income |
151 | 116 | 30.2% | 168 | (10.1)% |
| Adjusted net income | 106 | 68 | 55.9% | 142 | (25.4)% |
| Operating income | 985 | 116 | 749.1% | 189 | 421.2% |
| Net income | 928 | 68 | 1264.7% | 155 | 498.7% |
| Free cash flow* | (91) | 104 | (187.5)% | 137 | (166.4)% |
| Purchases of property, plant & equipment & intangible assets |
(127) | (106) | (19.8)% | (140) | 9.3% |



* See appendix for reconciliation of free cash flow
Numbers may not add due to rounding and set offs

| US\$ Million | Q1 2018 |
|---|---|
| Adjusted net income | 106 |
| Depreciation and amortization | 97 |
| Other adjustment to net income | (12) |
| Total changes to working capital* |
(155) |
| Net cash provided by operating activities |
36 |
| Purchases of PP&E & intangible assets |
(127) |
| Free cash flow** | (91) |

* Represents change in inventory + trade and other receivables + trade and other payables as per the statement of cash flows
** See Appendix to the presentation for a reconciliation of free cash flow
| \$ million | Q1 18 | 2017 |
|---|---|---|
| Adjusted income before tax |
137 | 528 |
| Normalized tax rate (including resource tax) | 23% | 26% |
| Normalized tax expenses | 32 | 136 |
| Carryforward losses not recorded for tax purposes | 3 | 19 |
| 35 | 151 | |
| 26% | 29% | |
| Other items (mainly exchange rate impact) | (2) | 1 |
| Adjusted income tax | 33 | 156 |
| Actual Effective tax rate |
24% | 30% |





Excluding G&A and unallocated expenses

Numbers may not add due to rounding and set offs



See appendix to this presentation for reconciliation of free cash flow



Numbers may not add due to rounding and set offs
21



Excluding G&A and unallocated expenses

Numbers may not add due to rounding and set offs
| Q4 2016 |
Q1 2017 |
Q2 2017 |
Q3 2017 |
Q4 2017 | Q1 2018 | |
|---|---|---|---|---|---|---|
| Cash flow from operations | 257 | 195 | 199 | 176 | 277 | 36 |
| Purchase of property, plant and equipment and intangible assets |
(138) | (106) | (113) | (98) | (140) | (127) |
| Dividend from investees | 8 | 3 | - | - | - | - |
| Proceeds from sale of fixed assets |
- | 12 | - | - | - | - |
| Free Cash Flow | 127 | 104 | 86 | 78 | 137 | -91 |

We disclo se in this Quarterly Repo rt non-IFRS financial measures titled adjusted operating income, adjusted net income att ributable t o the Company's shareholder s, adjusted EBITDA and free cash flow. Our management uses adju sted operating income, adju sted net income att ributable t o the Company's shareholder s and adju sted EBITDA t o facilitate operating per fo rmance compariso ns from period to period and present free cash flow t o facilitate a review o f our cash flows in period s. We calculate our adju sted operating income b y adju sting our operating income to add certain items, as set fo rt h in t he reconciliation table "Adju stment s to repo rted operating and net income" abo ve. Certain o f t hese items may recur. We calculate our adju sted net income att ributable to t he Company's shareholder s b y adju sting our net income attributable to t he Company's shareholders to add certain items, as set fo rt h in t he reconciliation table "Adju stment s to reported operating and net income" above, excluding t he total tax impact o f such adju stment s and adju stment s att ributable to t he non-cont rolling interest s. We calculate our adju sted EBITDA by adding back to t he net income att ributable to t he Company's shareholder s t he depreciation and amo rtization, financing expenses, net, taxes o n income and t he items presented in t he reco nciliation table "Adju sted EBITDA fo r t he periods o f activit y" below which were adju sted fo r in calculating t he adju sted operating income and adju sted net income att ributable to t he Company's shareholders. We calculate our free cash flow as our cash flows from operating activities net o f our purchase o f propert y, plant, equipment and intangible asset s, and adding Proceeds from sale o f propert y, plant and equipment and Dividend s from equit y-accounted investees during such period as presented in t he reconciliation table under "Calculation o f free cash flow".
You should not view adju sted operating income, adju sted net income att ributable to t he Company's shareholder s o r adju sted EBITDA as a substit ute fo r operating income o r net income att ributable t o the Company's shareholder s determined in acco rdance wit h IFRS, o r free cash flow as a substit ute fo r cash flows from operating activities and cash flows u sed in investing activities, and you should note t hat our de finitions o f adju sted operating income, adju sted net income att ributable to t he Company's shareholder s, adju sted EBITDA and free cash flow may differ from t ho se used b y ot her companies. However, we believe adju sted operating income, adju sted net income att ributable to t he Company' s shareholder s, adjusted EBITDA and free cash flow provide u se ful in fo rmation t o bot h management and invest o rs by excluding certain expenses t hat management believes are not indicative o f our ongoing operatio ns. In particular fo r free cash flow, we adju st our Capex to include any Proceeds from sale o f propert y, plant and equipment becau se we believe such amount s o ffset the impact o f our purchase o f propert y, plant, equipment and intangible asset s. We furt her adju st free cash flow t o add Dividend s from equit y-accounted investees because receipt o f such dividends a ffect s our residual cash flow. Free cash flow does not reflect adju stment fo r additional items t hat may impact our residual cash flow fo r discretionar y expendit ures, such as adju stment s fo r charges relating t o acquisitions, ser vicing debt obligations, changes in our depo sit account balances t hat relate t o our investing activities and ot her non-discretionar y expendit ures. Our management uses t hese non-IFRS measures t o evaluate t he Company's bu siness st rategies and management 's per fo rmance. We believe t hat t hese non-IFRS measures provide u se ful info rmation t o invest o rs becau se t he y improve t he comparabilit y o f t he financial result s between periods and provide fo r greater t ransparency o f key measures used t o evaluate our per fo rmance.
We present a discu ssio n in t he period-t o-period compariso ns o f t he primar y driver s o f changes in t he company's result s o f operations. This discu ssio n is based in part o n management 's best estimates o f t he impact o f t he main t rends in it s businesses. We have based t he following discussio n o n our financial statement s. You should read t he following discussion t oget her wit h our financial statement s.

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.